Trump announces reforms to accelerate access to psychedelic drug treatments
President Trump signed an executive order to accelerate FDA review of psychedelic treatments like ibogaine for PTSD and addiction.
Good Look
tl;dr
President Trump signed an executive order to expedite FDA review and federal research for psychedelic treatments like ibogaine, specifically targeting PTSD and opioid addiction.
Discussion
What's your take?
Loading comments...